✦ LIBER ✦

1082 – 40-week, randomized, double-blind, placebo-controlled, multicenter, efficacy and safety study of methylphenidate hydrochloride modified release (MPH-LA) in adults with attention deficit hyperactivity disorder (ADHD)

✍ Scribed by Huss, M.; Ginsberg, Y.; Philipsen, A.; Tvedten, T.; Arngrim, T.; Greenbaum, M.; Carter, K.; Chen, C.-W.; Kumar, V.

Book ID: 122454316
Publisher: Elsevier Science
Year: 2013
Tongue: French
Weight: 17 KB
Volume: 28
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(13)76193-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylphenidate Hydrochloride Modified-R

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

✍ Huss, Michael; Ginsberg, Ylva; Tvedten, Torbjorn; Arngrim, Torben; Philipsen, Al 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 871 KB

EPA-0627 - Safety profile of methylpheni

EPA-0627 - Safety profile of methylphenidate hydrochloride-modified release (MPH-LA) in adults and children with attention deficit hyperactivity disorder

✍ Ginsberg, Y.; Arngrim, T.; Philipsen, A.; Gandhi, P.; Chen, C.W.; Kumar, V.; Hus 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 135 KB

Efficacy and Safety of Atomoxetine Hydro

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD: A Multinational 10-Week Randomized Double-Blind Placebo-Controlled Asian Study

✍ Goto, T.; Hirata, Y.; Takita, Y.; Trzepacz, P. T.; Allen, A. J.; Song, D.-H.; Ga 📂 Article 📅 2016 🏛 SAGE Publications 🌐 English ⚖ 390 KB

Efficacy of lisdexamfetamine dimesylate

Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

✍ Babcock, Thomas; Dirks, Bryan; Adeyi, Ben; Scheckner, Brian 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 381 KB

EPA-0666 – Long-term maintenance of effi

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

✍ Newcorn, J.; Harpin, V.; Huss, M.; Johnson, M.; Ramos-Quiroga, J.A.; Van Stralen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 74 KB

Efficacy and safety of the novel α4β2neu

Efficacy and safety of the novel α4β2neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

✍ George Apostol; Walid Abi-Saab; Christopher J. Kratochvil; Lenard A. Adler; Wein 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 321 KB